Do you want to read an article? Please log in or register.
A phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C
Hepatitis
Indications
Related content
Inflammatory Bowel Disease
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Lancet Gastroenterol Hepatol
Wu K, Zheng C, Cao Q, Ding Y, Gao X, Zhong J, Chiu CT, Zhang H, Wang X, Wang B, Liang J, Liu X, Zhou Y, Xu B, Kim TO, Shen X, Chen D, Chen W, Liu Y, Shen J, Liu F, Ding X, Zhan Q, Chou JW, Zeng S, Lin Y, Ying L, Chen X, ENLIGHT UC Study Group
doi: 10.1016/S2468-1253(25)00198-0
Hepatitis
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study
Lancet
Noureddin M, Harrison SA, Loomba R, Alkhouri N, Chalasani N, Sheikh MY, Tomah S, Gutierrez JA, Urbina S, Suschak JJ, Brown R, Odili O, Yang J, Keeton S, Neff G, Mena E, Roberts MS, Browne SK, Harris MS
doi: 10.1016/S0140-6736(25)02114-2
Hepatitis
Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A REAL-B study
Am J Gastroenterol
Li J, Liu JK, Chau A, Linden S, Tsai PC, Nozaki A, Vutien P, Uojima H, Toyoda H, Honda T, Trinh H, Abe H, Ishikawa T, Atsukawa M, Watanabe T, Tsuji K, Huang DQ, Takaguchi K, Itobayashi E, Marciano S, Rui F, Ni W, Takahashi H, Chuang WL, Dai CY, Huang JF, Huang CF, Yeh ML, Zhu Y, Itokawa N, Kozuka R, Inoue K, Senoh T, Maeda M, Ito T, Morimoto M, Cheung R, Gadano A, Enomoto M, Tanaka Y, Lim SG, Wu C, Yu ML, Nguyen MH
doi: 10.14309/ajg.0000000000003881
Hepatitis
Prediction of Hepatitis C Virus Perinatal Transmission in Pregnant Individuals With Hepatitis C Virus Infection
Obstet Gynecol
Sandoval GJ, Saade GR, Hughes BL, Clifton RG, Reddy UM, Bartholomew A, Salazar A, Chien EK, Tita ATN, Thorp JM Jr, Metz TD, Wapner RJ, Sabharwal V, Simhan HN, Swamy GK, Heyborne KD, Sibai BM, Grobman WA, El-Sayed YY, Casey BM, Parry S, Macones GA, Prasad M, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network
doi: 10.1097/AOG.0000000000005872
Inflammatory Bowel Disease
Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis
J Crohns Colitis
D'Haens G, Danese S, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV Jr, Kobayashi T, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S
doi: 10.1093/ecco-jcc/jjaf080
Hepatitis
A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles
Lancet Gastroenterol Hepatol
Hiebert-Suwondo L, Manning J, Tohme RA, Buti M, Kondili LA, Spearman CW, Hajarizadeh B, Turnier V, Lazarus JV, Grebely J, Dore GJ, Waked I, Ward JW, National Hepatitis Elimination Profile Collaborators
doi: 10.1016/S2468-1253(25)00068-8
Hepatitis
Estimating the annual number of hepatitis C virus infections through vertical transmission at country, regional, and global levels: a data synthesis study
Lancet Gastroenterol Hepatol
Trickey A, Artenie A, Feld JJ, Vickerman P
doi: 10.1016/S2468-1253(25)00189-X
HepatitisHepatology
Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies
Gut
Luo J, Hu M, Feng T, Zhang L, Huang Y, Huang Y, Ye F, Li J, Aguilar F, Sánchez-Garrido C, Usón-Raposo E, Zhu B, Zhou Q, Liang X, Li J, Li P, Xin J, Shi D, Zheng J, Zhang H, Wang B, Qiang W, Yao H, Zhou X, Chen J, Hu W, Li B, Ma S, Wu X, Li X, Kong Y, Sun F, Chen X, Wu T, Yang L, Sun S, Guo B, He L, Chen J, Xin S, Li X, Chen H, Angeli P, Jalan R, Lin B, Chen Y, You S, Chen X, Queiroz Farias A, Trebicka J, Jiang J, Moreau R, Li J, CANONIC, PREDICT, ACLARA Study Group, Chinese Group on the Study of Severe Hepatitis B (COSSH)
doi: 10.1136/gutjnl-2025-335651
Hepatitis
Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis
Hepatology
Li J, Xu L, Rui F, Tran S, Tsai PC, Tan Y, Toyoda H, Zeng QL, Trinh H, Hsu YC, Watanabe T, Abe H, Motoyama H, Yoshimaru Y, Suzuki T, Arai T, Atsukawa M, Vutien P, Marciano S, Bai X, Ni W, Geng N, Tseng CH, Liu J, Mi Y, Liu J, Ye Y, Zhu L, Chen RY, Zhu C, Maeda M, Liu JK, Henry L, Yeh ML, Huang CF, Huang JF, Dai CY, Gadano A, Cheung R, Chuang WL, Enomoto M, Tanaka Y, Aishima S, Yu ML, Wu C, Shi J, Nguyen MH
doi: 10.1097/HEP.0000000000001442